Skip to content
Search

Latest Stories

RPS publishes new core advanced pharmacist curriculum

The Royal Pharmaceutical Society (RPS) has published a new blueprint for advanced pharmacist core practice, following an intensive programme of work undertaken in collaboration with a wide range of UK stakeholders.

The the society said today (June 27) in a statement that the curriculum will equip pharmacists with advanced leadership, education, and research capabilities which are essential to support, lead and advance the profession through transformative change so it continues to meet evolving patient and service requirements.


The RPS Core Advanced Curriculum provides the blueprint to develop such individuals by articulating a UK entry-level standard to advanced pharmacist practice, relevant to all patient-focused pharmacist roles and aligned to multi-professional definitions of advanced practice.

This curriculum completes the core RPS post-registration curricula, creating a seamless post-registration professional development continuum modelled around five common domains- Person-centred care and collaboration; Professional practice; Leadership and management; Education; and Research.

From September 2022, pharmacists will be able to start compiling an electronic portfolio to demonstrate their learning and achievement of the curriculum outcomes. This forms the basis of the assessment, which will be carried out by an RPS competency committee.

“Successful completion of the curriculum’s assessment leads to the award of the RPS advanced pharmacist credential. This will demonstrate the pharmacist has demonstrated the necessary clinical and non-clinical capabilities required to practice at an advanced level,” said RPS.

RPS president Claire Anderson said: “The core advance curriculum bridges the gap between the post-registration foundation curriculum and the consultant pharmacist curriculum. It provides a blueprint for pharmacists to develop their potential and a way of being recognized as an integral part of the multi-professional advanced workforce.

"I’d like to thank everyone who has contributed to the production of this curriculum.”

Anne Watson, postgraduate pharmacy dean, NHS Education for Scotland, said: “NHS Education for Scotland welcomes the publication of the new RPS core advanced pharmacist curriculum which will support the vision of strengthening career development pathways in community, primary and secondary care as we outlined in our Pharmacist Career Framework review for Scotland 2020. It will enable pharmacists to provide quality assured care within an increasingly demanding and complex healthcare environment.”

Dr Jane Brown, pharmacy dean, Health Education England, said: “Health Education England welcomes the publication of the core advanced pharmacist curriculum. This approach will enable pharmacists from any sector to demonstrate holistic, advanced-level practice across the four pillars.

“The HEE team are pleased to have worked collaboratively with the RPS and other stakeholders in creating this curriculum. The curriculum supports development of the advanced pharmacist workforce and ensures parity with advanced clinicians from other professional groups.

“The curriculum’s alignment with the NHS Multi-professional framework for advanced clinical practice in England will allow HEE and the RPS to jointly support pharmacists in navigating the routes to advanced practice credentialing.”

Margaret Allan, dean at NHS health education and improvement, Wales, said: “HEIW welcomes the launch of the RPS Core Advanced Curriculum. The curriculum provides a clear trajectory for pharmacists from the post registration foundation curriculum into advanced practice.

"The significant changes to the pharmacist Initial education and training pathway means it is even more important that we have clearly defined post registration pathways from early years through to advanced and consultant practice. HEIW will look forward to working with colleagues to consider the implementation of the RPS Core Advanced Curriculum”

The society is also hosting a webinar on the advanced curriculum on 18 July 7-8pm.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less